Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

The Preclinical Natural History Of Serous Ovarian Cancer: Defining The Target For Early Detection
Ovarian cancer kills approximately 15,000 women in the United States every

Clean Fuels Could Reduce Deaths From Ship Smokestacks By 40,000 Annually
Rising levels of smokestack emissions from oceangoing ships will cause an estimated 87,000 deaths worldwide each year by 2012 - almost one-third higher than previously believed, according to the second major study on that topic. The study says that government action to reduce sulfur emissions from shipping fuel (the of air pollution linked to an increased risk of illness and death) could reduce that toll. The study is in the current issue of ACS" Environmental Science & Technology, a semi-monthly publication.
News of the day
RCN Launches New Sexual Health Skills Framework
The Royal College of Nursing (RCN) launched new guidance to help sexual and reproductive health nurses to provide the safest, most effective practice.
Mental Health

FDA Extends Review Period For Eurand's ZENPEPTM Pancreatic Enzyme Replacement Therapy

Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, announced that the U.S. Food and Drug Administration (FDA) has advised the Company that it has extended the June 2009 user fee goal date for the New Drug Application for ZENPEP™ (pancrelipase capsules) by three months. The FDA did not request that the Company provide any further information, but attributed the reason for the delay to the need for additional time to review the current submission. About ZENPEP (pancrelipase capsules) ZENPEP is a proprietary pancreatic enzyme product developed for the treatment of exocrine pancreatic insufficiency, a condition associated with cystic fibrosis, chronic pancreatitis and other diseases. The product was developed in response to the 2004 FDA initial guidance on pancreatic enzyme products, which outlined the need to reduce the variability in enzyme levels and stability of currently marketed enzyme therapies and regulate them under NDAs. ZENPEP is a highly stable formulation of a porcine pancreatic extract that is biologically similar to the endogenous human pancreatic secretions necessary for proper human digestion. Eurand


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009